Collapsing FSGS (other papers)

anchor is Collapsing FSGS

32598981 2020. Infections and Collapsing Glomerulopathy.
31378644 2019. Collapsing Lesions and Focal Segmental Glomerulosclerosis in Pregnancy: A Report of 3 Cases.
20116156 2010. Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.
12915777 2003. Podocyte biology and the emerging understanding of podocyte diseases.
20847290 2010. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.
19359523 2009. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
24154691 2014. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.
23926186 2013. Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.
23761678 2013. Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.
21429972 2011. Tubular proteinuria in mice and humans lacking the intrinsic lysosomal protein SCARB2/Limp-2.
21289056 2011. Role of smooth muscle protein SM22alpha in glomerular epithelial cell injury.
19195964 2009. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy.
15100732 2004. [An analysis of the clinical and pathological manifestations of adult idiopathic focal segmental glomerulosclerosis].
27294131 2016. Infection-Related Focal Segmental Glomerulosclerosis in Children.
27247945 2016. Practical Application of Columbia Classification for Focal Segmental Glomerulosclerosis.
30653858 2018. [Glomerulonefritis colapsante con marcadores de desdiferenciacion podocitaria en sindrome hemofagocitico secundario a linfoma hepatoesplenico de celulas T].
26197890 2015. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.
24666814 2014. Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.
26236343 2015. Collapsing Focal Segmental Glomerulosclerosis in a Patient with Acute Malaria.
27403357 2016. Collapsing Glomerulopathy in a Child with Galloway-Mowat Syndrome.
23198255 2011. De Novo Collapsing Glomerulopathy: An Unusual Cause of Early Graft Failure following Kidney Transplantation.
21541658 2012. Mechanisms and consequences of TGF-ss overexpression by podocytes in progressive podocyte disease.
30747351 2019. Collapsing glomerulopathy in a child with LCHAD deficiency: a rare association.
28509120 2017. Complex glomerular pathology of thrombotic microangiopathy and focal segmental glomerulosclerosis forms tumor-like mass in a renal transplant donor with severe renovascular hypertension.
28508976 2016. Idiopathic collapsing focal segmental glomerulosclerosis in an 81-year-old Japanese woman: a case report and review of the literature.
26101727 2015. Alendronate associated focal segmental glomerulosclerosis: a case report and review of the literature.
28596417 2017. Nephrotic Syndrome Post-Kidney Transplant.
27445167 2016. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
23220425 2013. Association of histologic variants in FSGS clinical trial with presenting features and outcomes.
21734084 2011. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
19808230 2009. Dystroglycan in the diagnosis of FSGS.
17699461 2007. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases.
17699485 2007. Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis.
28852479 2017. Collapsing glomerulopathy: a 30-year perspective and single, large center experience.
25878787 2014. Collapsing glomerulopathy after Plasmodium falciparum infection.
26120443 2013. Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab.
26069759 2012. Collapsing glomerulopathy with patchy acute cortical necrosis secondary to postpartum hemorrhage.
21426891 2011. Familial collapsing focal segmental glomerulosclerosis.
29043128 2015. Rapid progression to end-stage renal disease in a child with a sporadic ACTN4 mutation.
23470819 2013. Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.
19838113 2010. Susceptibility genes in common complex kidney disease.
16937370 2006. Math6 expression during kidney development and altered expression in a mouse model of glomerulosclerosis.
31142971 2019. Collapsing Glomerulopathy Superimposed on Diabetic Nephropathy.
29962672 2018. The Spectrum of Focal Segmental Glomerulosclerosis from Eastern India: Is It Different?
28904428 2017. Collapsing Glomerulopathy- A Troublemaker for the Renal Allograft: Lessons Learnt.
27795635 2016. Collapsing glomerulopathy associated with pulmonary tuberculosis.
27051140 2016. Collapsing glomerulopathy in a case of anti-neutrophil cytoplasmic antibody associated vasculitis.
25838648 2015. Collapsing glomerulopathy following anabolic steroid use in a 16-year-old boy with IgA nephropathy.
25684864 2015. Understanding podocytopathy and its relevance to clinical nephrology.
25120291 2014. Frequency and clinicopathological correlations of histopathological variants of pediatric idiopathic focal segmental glomerulosclerosis.
25097337 2014. Idiopathic collapsing glomerulopathy: A clinicopathologic analysis of 30 cases.
23087568 2012. Collapsing glomerulopathy: The Indian scenario.
22787325 2012. Collapsing glomerulopathy in renal allograft biopsies: A study of nine cases.
21655163 2011. Collapsing glomerulopathy in renal allograft biopsies: A study of nine cases.
19008578 2008. A case of collapsing glomerulopathy associated with febrile illness.
27437509 2014. The Impact of Histologic Variants on FSGS Outcomes.
21424374 2012. Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis.
26174454 2015. A clinicopathological study of C1q nephropathy at King Abdulaziz University.
24335975 2014. Extensive podocyte loss triggers a rapid parietal epithelial cell response.
22518006 2012. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
21784893 2011. Identification of the nephropathy-susceptibility locus HIVAN4.
20829409 2010. Glomerular epithelial stem cells: the good, the bad, and the ugly.
19917783 2010. Development of focal segmental glomerulosclerosis after anabolic steroid abuse.
19917779 2009. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.
18579640 2008. Fidelity and evolution of recurrent FSGS in renal allografts.
18287560 2008. Current views on collapsing glomerulopathy.
17855635 2007. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement.
16914539 2006. Collapsing glomerulopathy.
16120817 2005. The kd/kd mouse is a model of collapsing glomerulopathy.
15100361 2004. Reversal of collapsing glomerulopathy in mice with the cyclin-dependent kinase inhibitor CYC202.
15284302 2004. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
15034095 2004. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.
11373339 2001. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.
11158216 2001. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
9890309 1999. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.
9013450 1997. A reevaluation of routine electron microscopy in the examination of native renal biopsies.
1932637 1991. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis.
28355399 2017. Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies - REPEG.
23812568 2013. Histologic variants of primary focal segmental glomerulosclerosis: presentation and outcome.
28571148 2017. De Novo Focal Segmental Glomerulosclerosis in Renal Allograft-Histological Presentation and Clinical Correlation: Single Centre Experience.
27190812 2016. Collapsing Glomerulopathy: A Single Centre Clinicopathologic Study of Seven Years.
15343382 2004. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways.
12618525 2003. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.
25319549 2015. Insights into the renal pathogenesis in Schimke immuno-osseous dysplasia: A renal histological characterization and expression analysis.
21338490 2011. Collapsing glomerulopathy in sickle cell disease: a case report.
24772395 2014. Acute renal failure in a young female with vaginal bleeding with partial recovery.
24475423 2013. Frequency and clinicopathological characteristics of variants of primary focal segmental glomerulosclerosis in adults presenting with nephrotic syndrome.
24475392 2012. Collapsing focal segmental glomerulosclerosis: Increasing the awareness.
23757976 2013. Collapsing glomerulopathy: a lesion under-recognised in Pakistan.
19757715 2009. "Collapsing FSGS, a need of awareness".
27744657 2016. Pathogenesis of Focal Segmental Glomerulosclerosis.
28724797 2017. Increasing the level of peroxisome proliferator-activated receptor gamma coactivator-1alpha in podocytes results in collapsing glomerulopathy.
20185928 2010. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
27677082 2017. Podocyte and Parietal Epithelial Cell Interactions in Health and Disease.
25168828 2014. Morphologic variants of focal segmental glomerulosclerosis and their significance.
20828590 2010. Targeting podocyte-associated diseases.
29908693 2018. Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases.
26210730 2015. AJKD Atlas of Renal Pathology: Collapsing Glomerulopathy.
23219112 2013. Collapsing glomerulopathy following anthracycline therapy.
21908087 2011. Collapsing glomerulopathy associated with natural killer cell leukemia: a case report and review of the literature.
19800721 2010. Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries.
18436095 2008. Familial focal segmental glomerulosclerosis associated with an ACTN4 mutation and paternal germline mosaicism.
17687807 2007. Quiz page. Collapsing FSGS.
16931223 2006. A case of Weber-Christian disease with collapsing glomerulopathy.
15112192 2004. Collapsing glomerulopathy in adult still's disease.
12955690 2003. Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients.
12200827 2002. Collapsing glomerulopathy: a cause of noncardiogenic pulmonary edema.
10196029 1999. Collapsing glomerulopathy: expanding interest in a shrinking tuft.
10196006 1999. Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations.
10196005 1999. Collapsing glomerulopathy: clinical characteristics and follow-up.
9856511 1998. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy.
7485126 1995. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study.

21358653 2011. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
21178978 2011. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
19180149 2009. Collapsing glomerulopathy: beyond serendipity in mouse genetics.
18309347 2008. Collapsing glomerulopathy: many means to a similar end.
18185509 2008. Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease.
18094678 2008. CDK/GSK-3 inhibitors as therapeutic agents for parenchymal renal diseases.
18235438 2008. Collapsing glomerulopathy associated with inherited mitochondrial injury.
17989648 2008. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).
17021605 2006. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
16518352 2006. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.
15673288 2005. Pathways to nephron loss starting from glomerular diseases-insights from animal models.
12969141 2003. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
12472788 2003. Familial collapsing glomerulopathy: clinical, pathological and immunogenetic features.
12631353 2003. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.
12110009 2002. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases.
10916090 2000. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
8914044 1996. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.
8072254 1994. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.
21221075 2011. TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha.
30327500 2019. Collapsing glomerulopathy in older adults.
27015134 2016. Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.
22227662 2012. Telomerase at the center of collapsing glomerulopathy.
22138751 2011. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling.
25447132 2015. Causes and pathogenesis of focal segmental glomerulosclerosis.
25473406 2014. Collapsing focal segmental glomerulosclerosis resulting from a single dose of zoledronate.
25749331 2014. [HIV-associated nephropathy with amoebic enteritis: a case report and literature review].
27977723 2016. Functional Validation of an Alpha-Actinin-4 Mutation as a Potential Cause of an Aggressive Presentation of Adolescent Focal Segmental Glomerulosclerosis: Implications for Genetic Testing.
23559294 2012. Glomerulopatia colapsante.
28540902 2017. Primary focal segmental glomerulosclerosis recurring rapidly as collapsing glomerulopathy in a renal allograft recipient.
25579744 2015. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
23354185 2013. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases.
22982914 2012. Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features.
18711298 2008. De novo collapsing glomerulopathy in a renal allograft recipient.
28439601 2017. Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literature.
32523052 2020. Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease.
20807613 2010. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
24175240 2012. Collapsing focal segmental glomerulosclerosis: Current concepts.
19581797 2009. Pamidronate-induced kidney injury in a patient with metastatic breast cancer.
25420079 2016. Unusual Cause and Presentation of Collapsing Focal Segmental Glomerulosclerosis.
21716195 2011. Collapsing glomerulopathy in a renal transplant recipient: potential molecular mechanisms.
15364701 2004. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder.
21416249 2011. Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.
20224877 2010. Collapsing FSGS: a clinicopathologic study of 10 cases from Pakistan.
18392736 2008. Idiopathic collapsing glomerulopathy in children.
20860901 2010. Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression.
11680656 2001. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.
21623907 2011. Focal segmental glomerulosclerosis after renal transplantation.
18408478 2008. The spectrum of focal segmental glomerulosclerosis: new insights.
15090854 2004. The role of VEGF-A in glomerular development and function.
12698062 2003. Update in podocyte biology: putting one's best foot forward.
19102117 2008. Le syndrome nephrotique avec hyalinose segmentaire et focale a Dakar: aspects epidemiologiques et anatomocliniques (a propos de 134 cas).
16971968 2006. CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases.
30315938 2019. WDR73-related galloway mowat syndrome with collapsing glomerulopathy.
15703275 2005. Definition of the critical domains required for homophilic targeting of mouse sidekick molecules.
30550036 2018. [FSGS collapsing variant during anabolic steroid abuse: Case Report].
15168339 2004. Pulmonary lymphoid lesions in an experimental model of collapsing glomerulopathy in rats.
10383699 1999. Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy.
24439928 2014. Combined crystalline podocytopathy and tubulopathy associated with multiple myeloma.
12055680 2002. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.
15630049 2005. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
15022922 2003. Multiple myeloma presenting as collapsing glomerulopathy.
15085081 2004. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
21721438 2011. Acute kidney injury in primary nephrotic syndrome: report of nine cases in Siriraj Hospital.
28470475 2018. Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.
24081220 2014. Clofarabine-induced kidney toxicity.
17319485 2006. Renal effects of opioid exposure: considerations for therapeutic use.
9602701 1998. Glomerular pathology: recent advances.
9407451 1997. Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants.
30554809 2019. Actualizacion de la glomerulopatia colapsante.
20865462 2011. Nephrotic syndrome induced by pamidronate.
19789521 2009. Prognostic value of clinical, laboratory, and morphological factors in patients with primary focal segmental glomerulosclerosis - distribution of pathological variants in the Croatian population.
12012394 2002. Modulation of podocyte phenotype in collapsing glomerulopathies.
16932363 2005. Mechanisms of disease: focal segmental glomerulosclerosis.
19474828 2009. Monoclonal antibodies for podocytopathies: rationale and clinical responses.
32191308 2020. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
30649467 2020. Utility of Columbia classification in focal segmental glomerulosclerosis: renal prognosis and treatment response among the pathological variants.
26160893 2016. The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation.
24081860 2014. Collapsing glomerulopathy superimposed on diabetic nephropathy: insights into etiology of an under-recognized, severe pattern of glomerular injury.
22859792 2013. Immunohistochemical expression of podocyte markers in the variants of focal segmental glomerulosclerosis.
21106772 2011. Collapsing glomerulopathy in Portugal: a review of the histological and clinical findings in HIV and non-HIV patients.
19589787 2009. Primary focal segmental glomerulosclerosis in adults: is the Indian cohort different?
17704112 2008. Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome.
16705026 2006. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
14767032 2004. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
9509474 1998. Collapsing glomerulopathy--recurrence in a renal allograft.
29191574 2018. Hyalinose segmentaire et focale collapsante secondaire au cytomegalovirus : a propos d'un cas.
23816889 2013. Hyalinose segmentaire et focale primitive de l'enfant : epidemiologie et facteurs pronostiques.
15663641 2004. Glomerulosclerosis: a paraneoplastic phenomenon?
10771575 2000. [A case of collapsing variant of FSGS].
7551013 1995. A collapsing form of glomerulopathy.
18276083 2008. Collapsing glomerulopathy in Galloway-Mowat syndrome: a case report and review of the literature.
15022071 2004. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators.
21125407 2011. Problems with 'focal segmental glomerulosclerosis'.
20195645 2010. Primary focal segmental glomerulosclerosis in Egyptian children: a 10-year single-centre experience.
17149638 2007. Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients.
17058050 2007. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis.
15723268 2005. Rapid development of glomerular injury and renal failure in mice lacking p53R2.
10684363 2000. Idiopathic collapsing glomerulopathy in children.
27266801 2016. A prospective study of collapsing focal segmental glomerulosclerosis.
25857429 2015. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases.
20113281 2010. Tuberculosis-associated collapsing glomerulopathy: remission after treatment.
20722570 2010. Challenges in clinical-pathologic correlations: acute tubular necrosis in a patient with collapsing focal and segmental glomerulosclerosis mimicking rapidly progressive glomerulonephritis.
10972063 1999. Glomerulopatia colapsante: una nueva entidad asociada a sindrome nefrotico e insuficiencia renal terminal.
15008214 2003. Classification histologique des maladies glomerulaires chroniques.
12180632 2002. Collapsing glomerulopathy--a new pattern of renal injury.
12704581 2003. Collapsing glomerulopathy.
12704573 2003. E pluribus unum: The riddle of focal segmental glomerulosclerosis.
12704572 2003. Pathologic classification of focal segmental glomerulosclerosis.
25645765 2015. Renal transplantation in children with nephrotic syndrome in the first year of life.
9603167 1998. De novo collapsing glomerulopathy in renal allografts.
9565112 1998. Recurrent collapsing glomerulopathy.
23262784 2013. A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis.

25704355 2015. Novel therapies for FSGS: preclinical and clinical studies.
25168834 2014. Mechanisms of disease reversal in focal and segmental glomerulosclerosis.
25168830 2014. Permeability factors in focal and segmental glomerulosclerosis.
25168829 2014. The pathogenesis of focal segmental glomerulosclerosis.
24602470 2014. Novel biomarkers in glomerular disease.
21896374 2011. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
31655844 2019. Collapsing Focal Segmental Glomerulosclerosis with Acute Interstitial Nephritis Associated with Plasmodium Falciparum: A Case Report and Review of the Literature.
31017877 2019. Post-Streptococcal Glomerulonephritis in Two Patients Following Deceased Donor Kidney Transplant.
30100602 2018. Multiple Myeloma in a Patient with Focal Segmental Glomerulosclerosis: A Case Report.
28522794 2017. Casual or Causal? Two Unique Cases of Hodgkin's Lymphoma: A Case Report and Literature Review.
25575099 2015. Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient.
24367720 2013. Membranous glomerulonephritis associated with Mycobacterium shimoidei pulmonary infection.
24840607 2014. The glomerulopathy of sickle cell disease.
30661770 2019. TBC1D8B Loss-of-Function Mutations Lead to X-Linked Nephrotic Syndrome via Defective Trafficking Pathways.
25466283 2014. Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome.
18308289 2008. Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis.
24461730 2014. New insights into molecular mechanisms of diabetic kidney disease.
23896482 2013. Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures.
21868143 2011. Podocyte disorders: Core Curriculum 2011.
21715071 2011. Podocyte biology for the bedside.
19932542 2010. Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group.
27001912 2016. Extending the mutation spectrum for Galloway-Mowat syndrome to include homozygous missense mutations in the WDR73 gene.
30965344 2019. Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.
27626625 2016. Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts.
21822010 2011. Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.
16282678 2005. Glomerular and tubular epithelial defects in kd/kd mice lead to progressive renal failure.
26073036 2015. Dendrin ablation prolongs life span by delaying kidney failure.
26072030 2015. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
25307344 2014. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
24007883 2013. New insights into the pathology of podocyte loss: mitotic catastrophe.
23769837 2013. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease.
21281782 2011. Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats.
21718676 2011. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture.
20829436 2010. Induction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndrome.
20522651 2010. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.
19834063 2009. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.
15039229 2004. Differential expression of d-type cyclins in podocytes in vitro and in vivo.
25673770 2015. MicroRNAs and the regulation of aldosterone signaling in the kidney.
20484657 2010. ANG II promotes autophagy in podocytes.
30838872 2019. Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors.
30943069 2019. Targeting STAT3 signaling in kidney disease.
29537311 2018. Casein kinase 1epsilon and 1alpha as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8.
28931521 2018. PGC1alpha in the kidney.
30256126 2018. Automatic glomerular identification and quantification of histological phenotypes using image analysis and machine learning.
28615246 2017. Src family kinases in chronic kidney disease.
27852611 2017. The critical role of Kruppel-like factors in kidney disease.
27440779 2016. Reducing mTOR augments parietal epithelial cell density in a model of acute podocyte depletion and in aged kidneys.
26739888 2016. TGF-beta signaling in the kidney: profibrotic and protective effects.
25587125 2015. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated beta1-integrin endocytosis.
26017974 2015. Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age.
24598802 2014. Mpv17 in mitochondria protects podocytes against mitochondrial dysfunction and apoptosis in vivo and in vitro.
24197069 2014. Stem cells: potential and challenges for kidney repair.
24338822 2014. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.
22129965 2012. De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.
21177778 2011. Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection.
20668098 2010. Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.
20630940 2010. Proteomic analysis identifies insulin-like growth factor-binding protein-related protein-1 as a podocyte product.
20660016 2010. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.
20007346 2010. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
19955187 2010. Conditionally immortalized human podocyte cell lines established from urine.
19794110 2009. A new function for parietal epithelial cells: a second glomerular barrier.
18784258 2008. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2.
30899410 2019. Engineering renal epithelial cells: programming and directed differentiation towards glomerular podocyte's progenitor and mature podocyte.
28804538 2017. Exendin-4-assisted adipose derived mesenchymal stem cell therapy protects renal function against co-existing acute kidney ischemia-reperfusion injury and severe sepsis syndrome in rat.
28556519 2017. Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.
26640759 2015. C1q Nephropathy: The Unique Underrecognized Pathological Entity.
23560233 2013. Molecular regulation of kidney development.
25877817 2015. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
26863327 2016. Vascular Growth Factors and Glomerular Disease.
22054238 2012. Cell biology and pathology of podocytes.
22490322 2012. Heterogeneity of coenzyme Q10 deficiency: patient study and literature review.
32500044 2020. Update on the etiology, classification, and management of glomerular diseases.
32693109 2020. GSK3 modulation in acute lung injury, myocarditis and polycystic kidney disease-related aneurysm.
21990098 2011. Primary and secondary CoQ(10) deficiencies in humans.
19096106 2008. Human CoQ10 deficiencies.
25789166 2014. Nephrin - a biomarker of early glomerular injury.
28951873 2017. Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.
28835895 2017. Antiangiogenic Therapy for Diabetic Nephropathy.
27429987 2016. Focal Segmental Glomerulosclerosis: Genetics, Mechanism, and Therapies.
27314022 2016. FSGS: Diagnosis and Diagnostic Work-Up.
27200372 2016. Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates.
27144163 2016. FSGS Recurrence in Adults after Renal Transplantation.
25866774 2015. New insights into glomerular parietal epithelial cell activation and its signaling pathways in glomerular diseases.
32102312 2020. The Role of PGC-1alpha and Mitochondrial Biogenesis in Kidney Diseases.
18689451 2008. Dynamic viscoelasticity of actin cross-linked with wild-type and disease-causing mutant alpha-actinin-4.
20462963 2010. Kidney disease associated with plasma cell dyscrasias.
29145816 2017. Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed.
23768159 2013. Glucose-induced gradual phenotypic modulation of cultured human glomerular epithelial cells may be independent of Wilms' tumor 1 (WT1).
31660881 2019. A steroid-resistant nephrotic syndrome in an infant resulting from a consanguineous marriage with COQ2 and ARSB gene mutations: a case report.
27090781 2016. Mice lacking microRNAs in Pax8-expressing cells develop hypothyroidism and end-stage renal failure.
25888165 2015. MKL1 inhibits cell cycle progression through p21 in podocytes.
31438882 2019. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
30340546 2018. Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report.
30466397 2018. Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models.
30419839 2018. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review.
26156092 2015. Focal segmental glomerulosclerosis: molecular genetics and targeted therapies.
26670137 2015. Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis.
25881298 2015. Loss of Dgcr8-mediated microRNA expression in the kidney results in hydronephrosis and renal malformation.
23663351 2013. A novel TRPC6 mutation in a family with podocytopathy and clinical variability.
23855530 2013. Changes in the histological spectrum of glomerular diseases in the past 16 years in the North-Eastern region of Romania.
24308295 2013. Glomerular tip adhesions predict the progression of IgA nephropathy.
23547922 2013. Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.
22727088 2012. A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood.
26856980 2016. Insight to changing morphologic patterns of glomerulopathy in adult Pakistani patients: an institutional perspective.
24207130 2013. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
29018146 2017. ANCA and IgA glomerulonephritis all in one: prognosis and complications.
29127133 2017. Nephrotic syndrome and acute kidney injury induced by malathion toxicity.
27535734 2016. Posterior reversible encephalopathy syndrome in malignant hypertension secondary to focal segmental glomerulosclerosis.
22388441 2012. A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection.
17374231 2007. [Clinicopathologic study of different variants of focal segmental glomerulosclerosis].
21215188 2010. [Clinicopathological study of 212 children with primary focal segmental glomerular sclerosis].
16221337 2004. [Idiopathic collapsing glomerulopathy in children: report of two cases].

22669525 2011. The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse.
28988177 2017. Fabry disease due to D313Y and novel GLA mutations.
32503809 2020. Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.
19775281 2009. Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.
19508392 2009. Inhibiting glycogen synthase kinase-3 reduces endotoxaemic acute renal failure by down-regulating inflammation and renal cell apoptosis.
28321320 2017. Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature.
32774956 2020. Focal Segmental Glomerulosclerosis and Scheduled Pretransplant Plasmapheresis: A Timely Diagnosis of Nail-Patella Syndrome Avoided More Futile Immunosuppression.
25849672 2015. Bucillamine-induced membranous nephropathy with crescent formation in a patient with rheumatoid arthritis: case report and literature review.
23197957 2012. Steroid-responsive nephrotic syndrome and bilateral renal artery stenosis: a possible role for Angiotensin-mediated podocyte injury.
30402314 2018. A Case of Lenvatinib-Induced Focal Segmental Glomerulosclerosis (FSGS) in Metastatic Medullary Thyroid Cancer.
26301083 2015. The role of alpha-actinin-4 in human kidney disease.
22995171 2012. Nuclear hormone receptors in podocytes.
27232327 2016. Cell cycle re-entry sensitizes podocytes to injury induced death.
32393782 2020. Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation.
32094322 2020. Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis.
30858353 2019. Inhibiting 4E-BP1 re-activation represses podocyte cell cycle re-entry and apoptosis induced by adriamycin.
31801948 2019. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
30429458 2018. MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate.
29748623 2018. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
31042480 2019. Anaerobic Glycolysis Maintains the Glomerular Filtration Barrier Independent of Mitochondrial Metabolism and Dynamics.
28361304 2017. Parietal cells-new perspectives in glomerular disease.
20495826 2010. Primary cilia disappear in rat podocytes during glomerular development.
30925751 2019. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
30823476 2019. Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair.
31997159 2020. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
28509069 2012. A case of the "cellular variant" of focal segmental glomerulosclerosis with acute renal failure that remitted completely with oral steroid administration.
12974746 2003. What has the immune system got against the glomerular podocyte?
32146646 2020. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
22552385 2012. Nonfunction of the ECT2 gene may cause renal tubulointerstitial injury leading to focal segmental glomerulosclerosis.
19673933 2009. Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice.
19298532 2009. Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.
30962186 2019. Blood Microbiome Profile in CKD : A Pilot Study.
28242845 2017. Focal Segmental Glomerulosclerosis.
27940459 2017. A Multicenter Cohort Study of Histologic Findings and Long-Term Outcomes of Kidney Disease in Women Who Have Been Pregnant.
27654928 2017. Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.
27340287 2016. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
26912551 2016. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.
27269610 2016. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.
25876771 2015. Drug-induced glomerular disease: attention required!
25862776 2015. Drug-induced glomerular disease: direct cellular injury.
25035273 2014. Nephrotoxic effects of common and emerging drugs of abuse.
23990165 2014. Glomerular diseases: FSGS.
24948143 2014. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
24651072 2014. American Society of Nephrology clinical pathological conference.
23886564 2013. A patient with nephrotic-range proteinuria and focal global glomerulosclerosis.
23868898 2013. Kidney disease and multiple myeloma.
24009220 2013. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
22917699 2012. Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.
22859745 2012. A case of late kidney allograft failure: a clinical pathological conference from American Society of Nephrology Kidney Week 2011.
20299374 2010. The spectrum of MYH9-associated nephropathy.
19578004 2009. Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.
29942497 2018. Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients.
26985375 2016. Minimal change disease onset observed after bevacizumab administration.
26613029 2015. A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.
25503953 2014. Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.
10627491 2000. Glomerulopathy associated with parasitic infections.
28522940 2017. Potential urine proteomics biomarkers for primary nephrotic syndrome.
22550230 2012. Mammalian kidney development: principles, progress, and projections.
28857521 2017. IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.
22573336 2012. Insights into the genetic architecture of diabetic nephropathy.
24396279 2013. Actin-associated Proteins in the Pathogenesis of Podocyte Injury.
23176147 2013. Podocyte mitosis - a catastrophe.
32132388 2020. The glomerular crescent: triggers, evolution, resolution, and implications for therapy.
30451737 2019. Genes and environment in chronic kidney disease hotspots.
27367910 2016. Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.
25415616 2015. JAK inhibition and progressive kidney disease.
20051853 2010. Essential hypertension and risk of nephropathy: a reappraisal.
18660675 2008. Therapeutic targets in focal and segmental glomerulosclerosis.
29123971 2017. Concepts of Genomics in Kidney Transplantation.
20818733 2010. Coenzyme Q and mitochondrial disease.
25475434 2015. Semaphorin3a promotes advanced diabetic nephropathy.
21521871 2011. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-beta: a model for diabetic podocytopathy.
30459215 2018. Modeling epigenetic modifications in renal development and disease with organoids and genome editing.
28487070 2017. Noncoding RNA and epigenetic gene regulation in renal diseases.
21286234 2010. Models of chronic kidney disease.
26086034 2014. Human Kidney Disease-causing INF2 Mutations Perturb Rho/Dia Signaling in the Glomerulus.
23592557 2013. Resolution of inflammation: an integrated view.
21567994 2011. Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice.
19562370 2009. Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.
22421514 2012. MicroRNAs and the glomerulus.
14668046 2003. Trophic factors and cytokines in early diabetic glomerulopathy.
30112052 2018. Silence of IGFBP7 suppresses apoptosis and epithelial mesenchymal transformation of high glucose induced-podocytes.
28232870 2017. Recent advances in understanding and treating nephrotic syndrome.
26918173 2016. Podocytes.
26629332 2015. Following specific podocyte injury captopril protects against progressive long term renal damage.
23150520 2013. Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice.
20687922 2010. Angiogenesis and chronic kidney disease.
16686951 2006. A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy.
21622249 2011. Podocyte dysfunction in aging--related glomerulosclerosis.
25667580 2014. Genes and podocytes - new insights into mechanisms of podocytopathy.
28638822 2017. Extracellular Vesicles in Renal Pathophysiology.
32509715 2020. Two Children With Novel TRPC6 Spontaneous Missense Mutations and Atypical Phenotype: A Case Report and Literature Review.
30693275 2018. Acute Kidney Injury in Nephrotic Syndrome.
27148508 2016. Ethnic Differences in Childhood Nephrotic Syndrome.
27066465 2016. Pathology of Podocytopathies Causing Nephrotic Syndrome in Children.
24611049 2014. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease.
24470738 2013. Significance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables.
27053712 2016. Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
25027322 2014. The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.
20124285 2010. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
24529330 2014. Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosis.
21074826 2011. Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants.
32737423 2020. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
20142565 2010. Angiotensin receptor blocker protection against podocyte-induced sclerosis is podocyte angiotensin II type 1 receptor-independent.
29942774 2018. Cryptococcosis as a cause of nephrotic syndrome? A case report and review of the literature.
27933432 2017. Lupus pathobiology based on genomics.
32015604 2020. Membranous Nephropathy with Collapse: Poor Prognosis.
30983748 2019. Loss of Subpodocytic Space Predicts Poor Response to Tacrolimus in Steroid-Resistant Calcineurin Inhibitor-Naive Adult-Onset Primary Focal Segmental Glomerulosclerosis.
27795629 2016. Clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents.
27194832 2016. Unmasking of complements using proteinase-K in formalin fixed paraffin embedded renal biopsies.
23814413 2013. The spectrum of glomerular diseases in a single center: A clinicopathological correlation.
23814411 2013. Toward establishing a renal biopsy registry: A step in the right direction.

23439390 2012. The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis.
23087559 2012. Diffuse mesangial sclerosis - Report of two cases.
21769177 2011. Giant cell transformation of podocytes: A unique histological feature associated with cystinosis.
24741201 2014. Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.
20542138 2010. The glomerulus--a view from the outside--the podocyte.
23675111 2009. The Comparison of the Podocyte Expression of Synaptopodin, CR1 and Neprilysin in Human Glomerulonephritis: Could the Expression of CR1 be Clinically Relevant?
26261628 2015. Differential microRNA expression in the serum of patients with nephrotic syndrome and clinical correlation analysis.
26191171 2015. Ultrastructural pathological features of unilateral renal artery stenosis in the rats.
26191142 2015. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
18830387 2009. Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2).
21355940 2011. Fibroblasts and myofibroblasts in renal fibrosis.
22536541 2012. Ferritin in adult-onset still's disease: just a useful innocent bystander?
32664269 2020. Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
31847447 2019. Kidney Cells Regeneration: Dedifferentiation of Tubular Epithelium, Resident Stem Cells and Possible Niches for Renal Progenitors.
30939806 2019. Kidney Lipidomics by Mass Spectrometry Imaging: A Focus on the Glomerulus.
29914215 2018. Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.
27376269 2016. Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases.
23799361 2013. MicroRNA regulation in renal pathophysiology.
25210627 2014. Anti-VEGF Cancer Therapy in Nephrology Practice.
22844593 2012. An overview of molecular mechanism of nephrotic syndrome.
22693670 2012. Progress in pathogenesis of proteinuria.
22288013 2012. Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.
21904677 2011. Molecular and genetic basis of inherited nephrotic syndrome.
31372025 2019. Prevalence rates of histopathologic subtypes associated with steroid resistance in childhood nephrotic syndrome in Sub-Saharan Africa: a systematic review.
31190951 2019. Prospects of genetic testing for steroid-resistant nephrotic syndrome in Nigerian children: a narrative review of challenges and opportunities.
28546764 2017. Optimal management of primary focal segmental glomerulosclerosis in adults.
27418857 2016. Adrenocorticotropic hormone analog use for podocytopathies.
29354517 2015. The role of medications and their management in acute kidney injury.
30146584 2019. Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation.
28381748 2017. Post-infectious Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits Associated with Complement Factor H Mutation.
26196009 2015. Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome.
23802112 2013. Immunoglobulin A Nephropathy and Malaria falciparum Infection; a Rare Association.
23794512 2013. The regulation and function of microRNAs in kidney diseases.
31085678 2019. Exome-Based Rare-Variant Analyses in CKD.
30642877 2019. Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.
31278193 2019. Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney.
30143559 2018. Podocyte-Specific Induction of Kruppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
29572404 2018. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
29321142 2018. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.
29222396 2018. Insights into the Regulation of Collecting Duct Homeostasis by Small Noncoding RNAs.
29180393 2018. Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.
30002222 2018. The Human FSGS-Causing ANLN R431C Mutation Induces Dysregulated PI3K/AKT/mTOR/Rac1 Signaling in Podocytes.
29959196 2018. Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.
29866798 2018. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study.
28428331 2017. A Personalized Model of COQ2 Nephropathy Rescued by the Wild-Type COQ2 Allele or Dietary Coenzyme Q10 Supplementation.
28720684 2017. FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.
28232619 2017. MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.
28923913 2017. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
28620081 2017. Re-Examining Neutrophil Participation in GN.
27188840 2016. Challenges in Rare Variant Association Studies for Complex Kidney Traits: CFHR5 and IgA Nephropathy.
26823550 2016. Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD.
27020855 2016. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
26546258 2016. Medullary Microvascular Thrombosis and Injury in Sickle Hemoglobin C Disease.
26374607 2016. Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.
26251351 2016. Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers?
25967120 2016. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.
26260163 2016. HANAC Syndrome Col4a1 Mutation Causes Neonate Glomerular Hyperpermeability and Adult Glomerulocystic Kidney Disease.
25568177 2015. Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.
25406339 2015. Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.
25349197 2015. Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.
26152271 2015. The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic Lesions.
26038526 2015. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.
24676636 2014. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.
24652806 2014. Induction of retinol dehydrogenase 9 expression in podocytes attenuates kidney injury.
24652804 2014. TGF-beta-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.
24854282 2014. Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics.
24744440 2014. Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport.
24511128 2014. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.
24511118 2014. MicroRNA-17~92 is required for nephrogenesis and renal function.
23949797 2013. Human kidney cell reprogramming: applications for disease modeling and personalized medicine.
23949798 2013. Proteinuria impairs podocyte regeneration by sequestering retinoic acid.
23539760 2013. Podocytes are nonhematopoietic professional antigen-presenting cells.
22822076 2012. MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.
22302196 2012. The long and short of microRNAs in the kidney.
22241893 2012. Managing microvascular complications of diabetes with microRNAs.
21719782 2011. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis.
20688932 2010. Overexpression of VEGF165b in podocytes reduces glomerular permeability.
19713307 2009. Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome.
19357256 2009. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.
19875807 2009. Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.
18596122 2008. Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture.
18776121 2008. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.
18199804 2008. Podocytes contribute to the formation of glomerular crescents.
18337488 2008. Ectopic notch activation in developing podocytes causes glomerulosclerosis.
17942957 2007. NPHS2 variation in sporadic focal segmental glomerulosclerosis.
17182884 2007. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.
16337774 2006. The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions.
31073028 2019. Disruption of the exocyst induces podocyte loss and dysfunction.
22493483 2012. Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation.
20562105 2010. Up-regulation of the homophilic adhesion molecule sidekick-1 in podocytes contributes to glomerulosclerosis.
31799982 2020. Crystalline light chain proximal tubulopathy and podocytopathy: a case report.
30806447 2020. Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report.
31800161 2020. Kruppel-like factor 4 improves obesity-related nephropathy through increasing mitochondrial biogenesis and activities.
30950172 2019. Identification of cell and disease specific microRNAs in glomerular pathologies.
30362534 2019. Albumin induces CD44 expression in glomerular parietal epithelial cells by activating extracellular signal-regulated kinase 1/2 pathway.
27134877 2016. Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection.
26894074 2016. Crescentic Glomerulonephritis Associated with Pulmonary Tuberculosis.
25954654 2015. Brain and Lung Abscesses in a 48-year-old Man with Focal and Segmental Glomerulosclerosis.
30747722 2019. Nonimmune cell-derived ICOS ligand functions as a renoprotective alphavbeta3 integrin-selective antagonist.
27918307 2017. VEGF regulates local inhibitory complement proteins in the eye and kidney.
25689255 2015. Loss of Kruppel-like factor 6 cripples podocyte mitochondrial function.
25689250 2015. Kruppel-like factor 6 regulates mitochondrial function in the kidney.
24531545 2014. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
24642466 2014. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
24270420 2013. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
21911940 2011. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis.
21606599 2011. The targeted podocyte.
19287096 2009. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis.
8675651 1995. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
31973092 2020. VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy.
26239683 2015. Diabetic Nephropathy without Diabetes.
28660146 2017. Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study.

32232184 2020. The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.
22843670 2012. Aging in the glomerulus.
26987072 2016. Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.
29310486 2018. Focal segmental glomerulosclerosis in children complicated by posterior reversible encephalopathy syndrome.
32643956 2020. Monoclonal Gammopathy of Renal Significance-A Rare Renal Presentation: A Review of Cases Reported.
19270830 2009. A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage.
25964888 2015. Co-existence of thin basement membrane nephropathy with other glomerular pathologies; a single center experience.
24475395 2012. Focal segmental glomerulosclerosis; collapsing variant.
28197479 2015. Focal segmental glomerulosclerosis and end-stage kidney disease in children.
23814519 2013. Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.
27068024 2016. Aberrant Blood Vessel Formation Connecting the Glomerular Capillary Tuft and the Interstitium Is a Characteristic Feature of Focal Segmental Glomerulosclerosis-like IgA Nephropathy.
27617138 2016. The Genetics of Nephrotic Syndrome.
26311998 2015. The effects of A2B receptor modulators on vascular endothelial growth factor and nitric oxide axis in chronic cyclosporine nephropathy.
9131509 1997. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis.
25143333 2015. ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.
21808734 2011. Relevance of VEGF and nephrin expression in glomerular diseases.
26697207 2015. Plasma Exchange for the Recurrence of Primary Focal Segmental Glomerulosclerosis in Adult Renal Transplant Recipients: A Meta-Analysis.
31934669 2019. Early Detection of Active Glomerular Lesions in Dogs and Cats Using Podocin.
30010634 2018. Assessment of Kidney Function in Mouse Models of Glomerular Disease.
30429374 2018. Tyro3 is a podocyte protective factor in glomerular disease.
29925693 2018. Kruppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation.
29046486 2017. Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.
32685349 2020. COQ6 mutation in patients with nephrotic syndrome, sensorineural deafness, and optic atrophy.
29344506 2017. MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target.
31029503 2019. Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions.
28476557 2017. Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.
28756872 2017. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor alpha.
27998643 2017. Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.
26376129 2015. The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy.
23842188 2013. Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum-induced glomerulonephritis.
23014460 2013. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis.
23325076 2013. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.
21937979 2012. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
21866090 2012. Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis.
20588287 2010. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?
20130528 2010. Toward the development of podocyte-specific drugs.
19536080 2009. The cell cycle and acute kidney injury.
19847153 2009. The enigmatic parietal epithelial cell is finally getting noticed: a review.
18509321 2008. Urinary exosomal transcription factors, a new class of biomarkers for renal disease.
32154460 2020. Light Chain Crystal Podocytopathy in a Patient With Systemic Indolent B-Cell Lymphoma.
32154457 2020. Brazilian Network of Pediatric Nephrotic Syndrome (REBRASNI).
32647771 2020. Atazanavir Crystal-Induced Chronic Granulomatous Interstitial Nephritis.
32775822 2020. Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis.
32775821 2020. Single-Nephron GFR in Patients With Obesity-Related Glomerulopathy.
31701065 2019. Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade.
31701062 2019. Paraneoplastic Focal Segmental Glomerulosclerosis Associated With Acute Lymphocytic Leukemia.
31701055 2019. Rationale and Design for a Phase 1 Study of N-Acetylmannosamine for Primary Glomerular Diseases.
31890997 2019. Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.
31194182 2019. Cancer-Associated AA Amyloidosis Presenting as Crescentic Glomerulonephritis.
30596179 2019. Renal Complications in Pregnancy Preceding Glomerulonephropathy Diagnosis.
30596161 2019. Increasing Options for First-Line Therapy in Primary FSGS?
30276344 2018. Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation.
29340321 2018. Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.
29270487 2017. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.
29318217 2017. Anticancer Drug-Induced Acute Kidney Injury.
27990496 2016. Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.
29142929 2016. Glomerulopathy Associated With Moderate Obesity.
25018934 2012. Chapter 9: Infection-related glomerulonephritis.
32155690 2020. Genetic tests in children with steroid-resistant nephrotic syndrome.
31284363 2019. Acute kidney injury in the patient with cancer.
30254844 2018. Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease.
27957423 2016. Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma.
23946930 2013. Transforming growth factor-beta and the glomerular filtration barrier.
26889423 2012. Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis.
28392820 2017. Genetics of hereditary nephrotic syndrome: a clinical review.
27279890 2016. Bilateral iliac and popliteal arterial thrombosis in a child with focal segmental glomerulosclerosis.
19918242 2010. Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.
22377738 2012. Rituximab in immunologic glomerular diseases.
26702815 2015. Acute kidney injury in imported Plasmodium falciparum malaria.
31880296 2019. miR-206 Inhibits Cell Proliferation and Extracellular Matrix Accumulation by Targeting Hypoxia-Inducible Factor 1-alpha (HIF-1alpha) in Mesangial Cells Treated with High Glucose.
30551123 2018. Aerobic Exercise Training Alleviates Renal Injury by Interfering with Mitochondrial Function in Type-1 Diabetic Mice.
29209103 2017. HIV as a Cause of Immune Activation and Immunosenescence.
31336742 2019. Pathogenesis and Management of Acute Kidney Injury in Patients with Nephrotic Syndrome Due to Primary Glomerulopathies.
31277139 2019. Nephrotic syndrome associated with ramucirumab therapy: A single-center case series and literature review.
30593133 2018. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report.
30544390 2018. Inflammatory demyelinating neuropathies with focal segmental glomerulosclerosis: Two case reports.
27227951 2016. Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study.
27149502 2016. Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data.
25500702 2014. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.
17532010 2007. Roles for VEGF in the adult.
23538309 2013. Hypertension and chronic kidney disease: controversies in pathogenesis and treatment.
19417726 2009. Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.
21998196 2011. Splice variant-specific cellular function of the formin INF2 in maintenance of Golgi architecture.
20974805 2011. Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.
14701729 2004. Early glomerular filtration defect and severe renal disease in podocin-deficient mice.
24389070 2014. Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.
25126046 2014. Clinical presentations of coenzyme q10 deficiency syndrome.
21756023 2011. MYO1E mutations and childhood familial focal segmental glomerulosclerosis.
31481669 2019. Defects in t(6)A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome.
31341160 2019. The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression.
29184126 2017. Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.
24909261 2014. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.
20023659 2010. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis.
18794856 2008. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
24317117 2014. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
22406746 2012. A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.
21151138 2011. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
30894700 2019. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.
29760448 2018. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
26804019 2016. Mitochondrial dysfunction in inherited renal disease and acute kidney injury.
25003613 2014. Diabetic nephropathy--emerging epigenetic mechanisms.
24296626 2014. Genetics in kidney disease in 2013: Susceptibility genes for renal and urological disorders.
23856995 2013. The primary glomerulonephritides: a systems biology approach.
22231130 2012. Clinical role of the renal transplant biopsy.
21151207 2011. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.
25949405 2010. Nephrotic syndrome and renal failure as an unusual presentation of solid tumour.
25949300 2009. Alendronate-associated focal segmental glomerulosclerosis.
27798196 2017. Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.
24084325 2014. Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease.
22422866 2012. ARB protects podocytes from HIV-1 nephropathy independently of podocyte AT1.
21968013 2012. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
21378152 2011. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.

C4859143 2016. Podocytopathy.
C6553266 2019. SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma.
C7121279 ä. Infectious Complications of Transplantation.
C7123371 2018. Hyperlipidemias and Obesity.

31399967 2019. Role of Podocyte Injury in Glomerulosclerosis.
21330358 2011. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.
20453520 2010. Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy.
23234871 2012. Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury.
16340240 2006. Therapeutics in renal disease: the road ahead for antiproliferative targets.
19142027 2009. Signaling in regulation of podocyte phenotypes.
25960654 2015. Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis.
30400314 2018. Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease.
30417008 2018. The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.
32218109 2020. Crescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric Diet.
26722248 2015. Multiple myeloma with a previous diagnosis of focal segmental glomerulosclerosis: A case report and review of the literature.
28445931 2017. High glucose induces apoptosis via upregulation of Bim expression in proximal tubule epithelial cells.
24153005 2013. MicroRNA-independent roles of the RNase III enzymes Drosha and Dicer.
19568349 2009. Development of kidney glomerular endothelial cells and their role in basement membrane assembly.
19337405 2008. Role of VEGF in organogenesis.
30558655 2018. Galloway-Mowat syndrome in Taiwan: OSGEP mutation and unique clinical phenotype.
24327929 2013. A compendium of urinary biomarkers indicative of glomerular podocytopathy.
30591974 2020. Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?
29181713 2019. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
29637272 2018. COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.
26490951 2016. Calcium, TRPC channels, and regulation of the actin cytoskeleton in podocytes: towards a future of targeted therapies.
25925039 2016. The glomerular permeability factors in idiopathic nephrotic syndrome.
24928414 2015. MicroRNAs and their applications in kidney diseases.
24890338 2015. Defining nephrotic syndrome from an integrative genomics perspective.
24584664 2015. Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.
22660936 2013. MicroRNAs in renal development.
21656172 2012. Renal involvement in mitochondrial cytopathies.
21110043 2011. Pathogenesis and therapy of focal segmental glomerulosclerosis: an update.
20734088 2011. Cystinosis: practical tools for diagnosis and treatment.
20352456 2010. A conceptual framework for the molecular pathogenesis of progressive kidney disease.
19066979 2010. Familial forms of nephrotic syndrome.
18543005 2008. Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome.
17216262 2007. Pathophysiology of focal segmental glomerulosclerosis.
17647026 2007. Mechanisms of progression of chronic kidney disease.
15265159 2004. The pediatric nephrotic syndrome spectrum: clinical homogeneity and molecular heterogeneity.
32597007 2020. CD44 impacts glomerular parietal epithelial cell changes in the aged mouse kidney.
26438731 2015. Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival.
21698141 2011. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
18437205 2008. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease.
32569286 2020. Complement activation profile of patients with primary focal segmental glomerulosclerosis.
31461442 2019. A bigenic mouse model of FSGS reveals perturbed pathways in podocytes, mesangial cells and endothelial cells.
29049388 2017. An inducible mouse model of podocin-mutation-related nephrotic syndrome.
28796785 2017. Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia.
27415632 2016. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
26335102 2015. Complement Activation in Patients with Focal Segmental Glomerulosclerosis.
25875837 2015. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
25849723 2015. Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell culture.
24924335 2014. Podocytes degrade endocytosed albumin primarily in lysosomes.
24621598 2014. Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis.
24498182 2014. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
23457485 2013. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival.
22125642 2011. Novel retinoic acid receptor alpha agonists for treatment of kidney disease.
20877463 2010. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
20634963 2010. Systematic analysis of a novel human renal glomerulus-enriched gene expression dataset.
24381395 2014. Steroid-resistant nephrotic syndrome secondary to primary focal segmental glomerulosclerosis and smoldering multiple myeloma.
17637879 2007. Reversibility of pamidronate-associated glomerulosclerosis.
25271328 2014. MAGI-2 scaffold protein is critical for kidney barrier function.
19480064 2009. 8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.
31889913 2019. Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers.
23002699 2012. Acute tubular necrosis and renal failure in patients with glomerular disease.
32074217 2020. Novel kidney injury biomarkers in tropical infections: a review of the literature.
28793022 2017. Kidney involvement in malaria: an update.
30422124 2018. Small non-coding RNA expression in mouse nephrogenic mesenchymal progenitors.
31862892 2019. Mesenchymal Stromal Cells Induce Podocyte Protection in the Puromycin Injury Model.
31388051 2019. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
30283057 2018. Kidney-derived c-kit(+) progenitor/stem cells contribute to podocyte recovery in a model of acute proteinuria.
30464326 2018. Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.
30111886 2018. Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3beta pathway signaling.
29162887 2017. The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeleton.
28642464 2017. Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.
28819298 2017. Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts.
27353019 2016. Non-canonical NFkappaB activation promotes chemokine expression in podocytes.
17116414 2006. TRPC6 in glomerular health and disease: what we know and what we believe.
20492585 2010. Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.
26215864 2015. Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.
22958493 2012. VEGF and podocytes in diabetic nephropathy.
19615562 2009. Progression of glomerular and tubular disease in pediatrics.
24455610 2013. Multiple myeloma presenting with focal segmental glomerulosclerosis.
27104120 2016. Serum glomerular albumin permeability activity: association with rapid progression to end-stage renal disease in focal segmental glomerulosclerosis.
23577302 2013. A review on the role of quinones in renal disorders.
28966119 2017. WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion.
32586408 2020. Stem cells: a potential treatment option for kidney diseases.
28058051 2016. Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy.
21686224 2011. Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).
25005737 2015. The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome.
22424432 2012. Genomic biomarkers for chronic kidney disease.
17466922 2007. Transcriptional regulation of podocyte disease.
29026873 2017. Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants.
29189487 2018. Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.
10507310 1999. A review of immunologic diseases of the dog.
32355641 2020. Nephrotoxicity in cancer treatment: An overview.
28948159 2017. Podocyturia: Potential applications and current limitations.
24255888 2013. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.
29312858 2017. De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?
27011905 2016. Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.